BRASS Participants
Researchers and Collaborators
About BRASS

Recent Publications

  • Impact of changes in inflammation on estimated 10-year cardiovascular risk in rheumatoid arthritis. Abstract
  • Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort. Abstract
  • An evaluation of the patient-administered Rheumatoid Arthritis Disease Activity Index for assessing disease activity during pregnancy. Abstract
  • Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement. Abstract

The purpose of BRASS

The purpose of the Brigham and Women’s Rheumatoid Arthritis Sequential Study (BRASS), under the direction of Dr. Nancy Shadick and Dr. Michael Weinblatt, is to determine how genes can be used to predict whether Rheumatoid Arthritis (RA) will be mild or severe and to better understand how individuals respond to different drug treatments.
BRASS has over 1500 people diagnosed with RA who are patients at the Brigham & Women’s Hospital and who are followed in the clinic annually and sent questionnaires at six month intervals over a 15 year time span. Additionally, BRASS provides investigators with access to subsets of data as well as methodological support.

Find out more